SE0102309L - One-time pharmaceutical composition containing brivudine - Google Patents

One-time pharmaceutical composition containing brivudine

Info

Publication number
SE0102309L
SE0102309L SE0102309A SE0102309A SE0102309L SE 0102309 L SE0102309 L SE 0102309L SE 0102309 A SE0102309 A SE 0102309A SE 0102309 A SE0102309 A SE 0102309A SE 0102309 L SE0102309 L SE 0102309L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
brivudine
composition containing
time pharmaceutical
containing brivudine
Prior art date
Application number
SE0102309A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE0102309D0 (en
Inventor
Alessandro Casini
Bettina Stubinski
Attilio Crea
Original Assignee
Berlin Chemie Ag
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie Ag, Menarini Ricerche Spa filed Critical Berlin Chemie Ag
Publication of SE0102309D0 publication Critical patent/SE0102309D0/en
Publication of SE0102309L publication Critical patent/SE0102309L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

Use of brivudine in the preparation of an oral pharmaceutical composition for the once-a-day treatment of herpes zoster infections or post-herpetic neuralgia. The amount of brivudine in each dose may be between 50 and 300 mg, preferably 125 mg. Use of a once daily dosage regimen improves patient compliance.
SE0102309A 2001-01-03 2001-06-28 One-time pharmaceutical composition containing brivudine SE0102309L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI000009A ITMI20010009A1 (en) 2001-01-03 2001-01-03 PHARMACEUTICAL COMPOSITIONS CONTAINING BRIVUDINA FOR SINGLE DAILY ADMINISTRATION

Publications (2)

Publication Number Publication Date
SE0102309D0 SE0102309D0 (en) 2001-06-28
SE0102309L true SE0102309L (en) 2002-07-04

Family

ID=11446384

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102309A SE0102309L (en) 2001-01-03 2001-06-28 One-time pharmaceutical composition containing brivudine

Country Status (20)

Country Link
AT (1) AT6141U1 (en)
BE (1) BE1014522A5 (en)
CH (1) CH695662A5 (en)
CZ (1) CZ20012464A3 (en)
DK (1) DK177084B1 (en)
ES (1) ES2192456B1 (en)
FI (1) FI20011446A (en)
FR (1) FR2818907B1 (en)
GB (1) GB2370771A (en)
GR (1) GR1004012B (en)
HR (1) HRPK20010345B3 (en)
HU (1) HUP0102816A3 (en)
IE (1) IE20010413A1 (en)
IT (1) ITMI20010009A1 (en)
NL (1) NL1018431C2 (en)
PL (1) PL348480A1 (en)
PT (1) PT102642B (en)
SE (1) SE0102309L (en)
SK (1) SK287043B6 (en)
UA (1) UA76402C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239527B1 (en) * 2004-03-01 2006-11-16 M. Cruz Fernandez Gonzalez PHARMACOLOGICAL COMPOSITION OF TOPICAL USE FOR THE TREATMENT OF HERPES ZOSTER.
CN113712928A (en) * 2021-09-29 2021-11-30 重庆市力扬医药开发有限公司 Brivudine drug absorbed through oral mucosa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104857A1 (en) * 1982-09-28 1984-04-04 Beecham Group Plc Deoxyuridine compounds, methods for preparing them and their use in medicine
IT1170232B (en) * 1983-10-31 1987-06-03 Anna Gioia Stendardi THERAPEUTIC COMPOSITIONS WITH ANTI-VIRAL ACTIVITY
US5446031A (en) * 1991-04-24 1995-08-29 Yamasa Shuyu Kabushiki Kaisha 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives
WO1997025989A1 (en) * 1996-01-19 1997-07-24 Glaxo Group Limited Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application

Also Published As

Publication number Publication date
ITMI20010009A0 (en) 2001-01-03
FR2818907B1 (en) 2006-05-26
ES2192456A1 (en) 2003-10-01
PT102642A (en) 2002-07-31
PL348480A1 (en) 2002-07-15
CZ20012464A3 (en) 2002-08-14
DK177084B1 (en) 2011-07-11
GB2370771A (en) 2002-07-10
FI20011446A (en) 2002-07-04
HRPK20010345B3 (en) 2005-02-28
AT6141U1 (en) 2003-05-26
DK200101019A (en) 2002-07-04
CH695662A5 (en) 2006-07-31
PT102642B (en) 2003-06-30
IE20010413A1 (en) 2003-04-16
UA76402C2 (en) 2006-08-15
HUP0102816A2 (en) 2002-10-28
FI20011446A0 (en) 2001-07-03
GB0110682D0 (en) 2001-06-20
HRP20010345A2 (en) 2003-08-31
FR2818907A1 (en) 2002-07-05
SE0102309D0 (en) 2001-06-28
SK9572001A3 (en) 2003-03-04
GR20010100322A (en) 2002-10-08
HUP0102816A3 (en) 2005-01-28
ES2192456B1 (en) 2005-02-01
SK287043B6 (en) 2009-10-07
HU0102816D0 (en) 2001-09-28
GR1004012B (en) 2002-11-01
ITMI20010009A1 (en) 2002-07-03
BE1014522A5 (en) 2003-12-02
NL1018431C2 (en) 2002-07-05

Similar Documents

Publication Publication Date Title
EE200000532A (en) Use of pyrimidine derivatives for the preparation of a medicament for the treatment of HIV infection, a compound, a pharmaceutical composition containing it, a process for the preparation of a compound and a composition, and a combination preparation for use in
EA200200812A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING LOW DOSE OF ENTEKAVIR, AND ITS APPLICATION
BRPI0415007A (en) method for treating, preventing, modifying or administering pain and pharmaceutical composition
EE05404B1 (en) A quinuclidine derivative, its preparation and its use in the preparation of a medicament for the treatment of respiratory, urinary or gastrointestinal diseases, and a pharmaceutical composition containing it
AU7490700A (en) Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
BRPI0008228B8 (en) pharmaceutical composition containing n-benzoyl staurosporine and solubilizing agents
BR0012082A (en) Pharmaceutical formulation for administration comprising morphine and its use
BR0210489A (en) Oral pharmaceutical formulation, process for preparing it, use of the table, and method for preparing a cardiovascular disorder in a patient
AP2003002763A0 (en) Controlled release formulations for oral administration
DE60128263D1 (en) ION DEFICIT INDEPENDENT PHARMACEUTICAL FORMULATION WITH DELAYED RELEASE
DK1383752T3 (en) Deuterated 3-piperidinopropiophenones as well as drugs containing these compounds
BR0211198A (en) Pharmaceutical compositions and their use
ATA59499A (en) PHARMACEUTICAL PREPARATION CONTAINING TOLPERISON FOR ORAL ADMINISTRATION
WO2002011694A3 (en) Compositions and dosage forms for application in the oral cavity in the treatment of mykoses
AR036321A1 (en) METHOD AND PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF LATE APPEARANCE DYSCINESIA.
SE0102309L (en) One-time pharmaceutical composition containing brivudine
MXPA02011533A (en) NOVEL FORMULATIONS OF agr; 2, 4 DISULFOPHENYL N TERT BUTYLNITRONE.
EE200200551A (en) Pharmaceutical composition containing oligosaccharides, oligosaccharides, their preparation and therapeutic use
EA200701091A1 (en) OPTICAL PHARMACEUTICALS
HUP9901935A2 (en) Dosage kit for targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags)
NO302360B1 (en) NG-monomethyl-L-argininhydrokloridderivater
BR0202759A (en) Modified release pharmaceutical composition containing bupropion as active substance
DK1161254T3 (en) Treatment of autoimmune diseases with an extract of American ginseng
TR200101352A2 (en) One-day pharmaceutical composition containing brivudine
HUP0301337A2 (en) Oral pharmaceutical compositions containing terbinafine and their use

Legal Events

Date Code Title Description
NAV Patent application has lapsed